Inozyme Pharma, Inc. (INZY) - Quarterly Income Statement

Home
INZY
Financials

0.9997 (USD) • At close March 13, 2025

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2024 Q4	2024 Q3	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1	2019 Q4	2019 Q3	2019 Q2	2019 Q1
Revenue Numbers are in millions	0	0	0	0	1.976	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost of Revenue Numbers are in millions	0	0.195	0.188	0.182	0.306	0.333	0.331	0.324	0	0.299	0.285	0.281	0.281	0.167	0.167	0.158	0	0	0	0	0	0	0	0
Gross Profit Numbers are in millions	0	-0.195	-0.188	-0.182	1.67	-0.333	-0.331	-0.324	0	-0.299	-0.285	-0.281	-0.281	-0.167	-0.167	-0.158	0	0	0	0	0	0	0	0
Gross Profit Ratio Numbers are in millions	0	0	0	0	0.845	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Reseach & Development Expenses Numbers are in millions	22.473	19.89	21.57	19.111	17.807	13.341	11.666	11.857	13.837	12.191	10.007	11.814	13.551	9.346	8.22	6.603	7.036	25.174	7.877	6.406	5.279	3.317	3.489	4.134
General & Administrative Expenses Numbers are in millions	4.698	4.961	5.907	5.234	4.825	4.733	4.728	6.512	5.696	4.721	5.384	5.025	5.206	4.916	4.435	4.369	4.235	3.142	1.671	1.5	1.489	1.003	1.064	1.03
Selling & Marketing Expenses Numbers are in millions	0	0	0	0	-0.13	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
SG&A Numbers are in millions	4.698	4.961	5.907	5.234	4.695	4.733	4.728	6.512	5.696	4.721	5.384	5.025	5.206	4.916	4.435	4.369	4.235	3.142	1.671	1.5	1.489	1.003	1.064	1.03
Other Expenses Numbers are in millions	0	0	-0.003	-0.051	0.014	0.02	-0.028	-0.034	0	-0.197	-0.191	-0.105	-0.04	-0.065	0.057	-0.141	0.089	0.157	0.004	-0.003	0.01	-0.003	-0.014	-0.017
Operating Expenses Numbers are in millions	27.171	24.851	27.477	24.345	22.502	18.074	16.394	18.369	19.533	16.912	15.391	16.839	18.757	14.262	12.655	10.972	11.271	28.316	9.548	7.906	6.768	4.32	4.553	5.164
Operating Income Numbers are in millions	-27.171	-24.851	-27.665	-24.345	-22.808	-18.074	-16.394	-18.369	-19.533	-16.912	-15.391	-16.839	-18.757	-14.262	-12.655	-10.972	-11.271	-28.316	-9.548	-7.906	-6.768	-4.32	-4.553	-5.164
Operating Income Ratio Numbers are in millions	0	0	0	0	-11.543	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Other Income Expenses Net Numbers are in millions	0.097	0.281	0.632	0.998	1.264	1.436	0.811	0.965	0.989	0.54	0.13	-0.045	0.003	-0.018	0.115	-0.078	0.153	0.221	0.075	0.168	0.224	0.285	0.38	0.193
Income Before Tax Numbers are in millions	-27.074	-24.57	-27.033	-23.347	-21.544	-16.638	-15.583	-17.404	-18.544	-16.372	-15.261	-16.884	-18.754	-14.28	-12.54	-11.05	-11.118	-28.095	-9.473	-7.738	-6.544	-4.035	-4.173	-4.971
Income Before Tax Ratio Numbers are in millions	0	0	0	0	-10.903	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Income Tax Expense Numbers are in millions	0	0	0	-0.182	2.219	-0.208	-0.839	-1.172	0	-0.54	-0.321	0.045	-0.003	-0.047	-0.058	-0.063	-0.064	-0.064	-0.071	-0.171	-0.214	-0.288	-0.394	-0.21
Net Income Numbers are in millions	-27.074	-24.57	-27.033	-23.347	-21.544	-16.638	-15.583	-16.232	-18.544	-15.832	-14.94	-16.929	-18.754	-14.28	-12.54	-11.05	-11.118	-28.095	-9.473	-7.738	-6.544	-4.035	-4.173	-4.971
Net Income Ratio Numbers are in millions	0	0	0	0	-10.903	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS Numbers are in millions	-0.43	-0.39	-0.44	-0.38	-0.35	-0.29	-0.35	-0.37	0	-0.36	-0.38	-0.71	-0.79	-0.6	-0.53	-0.47	-0.61	-1.55	-0.47	-0.51	-0.43	-0.27	-0.28	-0.33
EPS Diluted Numbers are in millions	-0.43	-0.39	-0.44	-0.38	-0.35	-0.29	-0.35	-0.37	0	-0.36	-0.38	-0.71	-0.79	-0.6	-0.53	-0.47	-0.61	-1.55	-0.47	-0.51	-0.43	-0.27	-0.28	-0.33
EBITDA Numbers are in millions	-25.475	-22.959	-25.45	-21.84	-17.905	-16.305	-15.252	-16.762	-19.335	-16.723	-15.212	-16.661	-18.575	-14.095	-12.488	-10.814	-11.148	-28.273	-9.522	-7.881	-6.743	-4.3	-4.534	-5.145
EBITDA Ratio Numbers are in millions	0	0	0	0	-11.388	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Inozyme Pharma, Inc.

NASDAQ:INZY Add to watchlist

NASDAQ:INZY